Is Aethlon Medical Inc (AEMD) overvalued? · $2.5M cap
Aethlon Medical Inc (AEMD) is a medical devices company listed on US.
This page asks whether Aethlon Medical Inc (AEMD) looks expensive on cached numbers — not a short thesis.
Latest reported AEMD revenue for 2024-03-31 was $0. Net income was -$12.2M. Revenue was down 100.0% from 2023-03-31 to 2024-03-31. AEMD currently screens at market cap $2.5M.
AEMD currently screens at market cap $2.5M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next AEMD 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the AEMD stock page for the full model, not this heading.
Not investment advice.